Post Profile






Will Shareholder Lawsuit Trigger Theranos To Return Capital To Shareholders?

Theranos, the 13 year old blood testing company, announced last week that it would shutter its blood testing laboratories andshift its attention tomaking blood testing machines.I wrote about that shutdown optionin July. And last week I suggested that Theranos should return its capital to investors. On October 10, the Wall [...]
read more

share

Related Posts


Is Google Using Shareholder Capital Properly?

Business & Finance / Personal Finance : Savings Experiment

Investing expert Benjamin Graham, Warren Buffett's mentor, warns shareholders to pay careful attention to whether their companies give proper recognition to the interests of average outside shareholders. I fear that Google may not p...

Theranos Can't Stop Getting in Trouble With FDA

Business & Finance : Business from Newser

And the hits keep on coming for medial technology company Theranos. In an attempt to move on following a federal criminal investigation into its laboratories, Theranos announced it was submitting a Zika blood test for emergency-use ...

Theranos is being sued for inaccurate blood tests and false marketing

Business & Finance : Business Pundit

$9 billion startup Theranos is being sued in Northern California. The company is accused of falsely marketing its proprietary finger-prick blood test. The lawsuit says Theranos promoted itself as being compliant with all current reg...

Theranos lawsuits continue to stack up following massive blood test errors

Business & Finance : Business Pundit

Theranos recently voided two years worth of blood tests and now consumers are starting to file lawsuits against the $9 billion startup. Lawyers on behalf of a man named Casey Jones filed the second lawsuit against the company on Thu...

Why Theranos Should Return Its Capital To Investors

Business & Finance : Forbes: Business

Theranos, the formerly $9 billion company thatFORBESrevalued in July at$800 million, will shutter all its blood testing facilities. That's exactly what I wrote Theranos should do last July. And nowthe companyought to return to its i...

Comments


Copyright © 2016 Regator, LLC